Skip to main content
OpenTrials

Clinical trial condition

AL Amyloidosis

Explore clinical trials studying AL Amyloidosis. Study availability and eligibility vary by location and protocol.

54 public trials 21 recruiting studies
Refine in advanced search Browse all conditions

AL Amyloidosis trial results

Completed

A Study of Belantamab Mafodotin in Patients With Relapsed or Refractory AL Amyloidosis

NCT04617925

Conditions
AL Amyloidosis, Amyloidosis, Immune System Diseases, +10 more
Locations
  • Centre hospitalier Universitaire de Limoges - Limoges, France
  • University Hospital Heidelberg Heidelberg, Germany
  • General Hospital of Athens "Alexandra" Athens, Greece
  • Fondazione I.R.C.C.S Policlinico "San Matteo" Pavia, Italy
View Trial Details
Completed

Phase 1/2 Study of ZN-d5 for the Treatment of Relapsed or Refractory Light Chain (AL) Amyloidosis

NCT05199337

Conditions
AL Amyloidosis, Amyloidosis, Immune System Diseases, +10 more
Locations
  • University of Southern California Los Angeles, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Tulane University New Orleans, Louisiana, United States
  • Washington University St Louis, Missouri, United States
View all 21 locations
View Trial Details
Completed

A Study on the Management and Outcome of Patients With Systemic AL Amyloidosis in Europe

NCT04937777

Conditions
AL Amyloidosis, Amyloidosis, Immune System Diseases, +10 more
Locations
  • Allgemeines Krankenhaus Der Stadt Wien (General Hopsital), Universitätsklinik Für Innere Medizin I Klinische Abteilung Für Onkologie (Clinic of Internal Medicine I), Medizinische Universität Wien Vienna, Austria
  • University Hospital Ostrava, Clinic of Hematooncology Ostrava, Czechia
  • Centre Hospitalier Universitaire de Limoges, Department of Clinical Hematology and Cell Therapy Limoges, France
  • Service de Néphrologie, Hémodialyse Et Transplantation Rénale, Hôpital Jean Bernard, Chu Poitiers Poitiers, France
View all 13 locations
View Trial Details
Completed

Bendamustine and Dexamethasone in Patients With Relapsed AL Amyloidosis

NCT01222260

Conditions
AL Amyloidosis, Amyloidosis, Immune System Diseases, +10 more
Locations
  • Tufts Medical Center Boston, Massachusetts, United States
  • Boston Medical Center Boston, Massachusetts, United States
  • Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
  • Mt. Sinai Medical Center New York, United States
View Trial Details

Related conditions